Valuation Orion Oyj OTC Markets

Stocks

Market Closed - OTC Markets Other stock markets 11:13:09 2026-04-02 EDT			5-day change	1st Jan Change
82.75 ^USD	+4.81%		-.--%	+1.78%

07-06	Shilpa Biologicals Private Limited and Orion Corporation Expand Partnership to Develop and Supply Nivolumab Biosimilar for Europe	CI
06-30	Tenax Therapeutics, Inc. and Orion Corporation Enter Supply Agreement For Manufacture and Supply of Orally Administered Levosimendan Product	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	5,119	7,179	5,509	6,005	8,944	9,915	-	-
Change	-	40.25%	-23.26%	8.99%	48.95%	10.86%	-	-
Enterprise Value (EV) ¹	5,010	7,060	5,603	6,126	9,088	9,815	9,603	9,348
Change	-	40.91%	-20.65%	9.35%	48.35%	7.99%	-2.16%	-2.65%
P/E	26.5x	20.6x	25.5x	18.2x	17.9x	18x	15.3x	13.7x
PBR	6.86x	7.91x	6.19x	5.98x	6.97x	6.23x	5.04x	4.16x
PEG	-	0.3x	-0.7x	0.3x	0.3x	1.85x	0.8x	1.2x
Capitalization / Revenue	4.92x	5.36x	4.63x	3.89x	4.73x	4.77x	4.22x	3.91x
EV / Revenue	4.81x	5.27x	4.71x	3.97x	4.81x	4.72x	4.08x	3.68x
EV / EBITDA	17.3x	14.5x	17.2x	12x	13.2x	13.1x	10.9x	9.6x
EV / EBIT	20.6x	16.1x	20.4x	14.7x	14.4x	14.2x	11.8x	10.3x
EV / FCF	38.5x	21.7x	105x	29.7x	41.5x	20.3x	19.1x	15.4x
FCF Yield	2.6%	4.6%	0.95%	3.37%	2.41%	4.92%	5.23%	6.51%
Dividend per Share ²	1.5	1.6	1.62	1.64	1.8	1.907	2.113	2.358
Rate of return	4.11%	3.12%	4.13%	3.83%	2.83%	2.7%	3%	3.34%
EPS ²	1.38	2.49	1.54	2.35	3.56	3.907	4.612	5.14
Distribution rate	109%	64.3%	105%	69.8%	50.6%	48.8%	45.8%	45.9%
Net sales ¹	1,041	1,341	1,190	1,542	1,890	2,080	2,352	2,537
EBITDA ¹	289.1	487.1	326.4	509.4	688.3	752	883.9	974.2
EBIT ¹	243.3	439.6	274.9	416.6	631.6	689	814.5	905.5
Net income ¹	193.8	349.5	216.8	329.9	500.3	549.5	649.2	724.1
Net Debt ¹	-108.3	-118.7	93.3	121.7	144.4	-100.6	-312.7	-567.1
Reference price ²	36.52	51.24	39.27	42.78	63.65	70.50	70.50	70.50
Nbr of stocks (in thousands)	140,563	140,202	140,351	140,501	140,693	140,866	-	-
Announcement Date	2/10/22	2/9/23	2/13/24	2/25/25	2/12/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.08x	12.75x	25.97x	0.57%	1,070B
JOHNSON & JOHNSON	27.67x	6.37x	17.29x	2.06%	624B
ABBVIE INC.	31.08x	7.52x	15.39x	2.69%	450B
ROCHE HOLDING AG	17.65x	4.4x	10.87x	3.02%	328B
ASTRAZENECA PLC	23.53x	4.92x	13.75x	1.77%	292B
NOVARTIS AG	21.61x	5.56x	13.43x	2.84%	284B
NOVO NORDISK A/S	14.17x	5.28x	10.84x	3.53%	217B
AMGEN INC.	23.97x	6.34x	11.16x	2.75%	198B
GILEAD SCIENCES, INC.	-45.95x	5.59x	31.09x	2.5%	161B
Average	16.53x	6.53x	16.64x	2.42%	402.71B
Weighted average by Cap.	24.29x	7.93x	18.34x	1.97%